Sir Keir Starmer must urgently address problems with the NHS or risk missing out on future investment in Britain, the UK boss ...
Ever-Growing USA on MSN1d
Retratutide: Eli Lilly’s Groundbreaking Drug for Obesity & DiabetesIn the ever-evolving landscape of healthcare, groundbreaking innovations are not merely celebrated for their scientific ...
We recently published a list of 12 Best Quality Stocks to Invest in Now. In this article, we are going to take a look at ...
Tirzepatide and Semaglutide Improve Weight Loss, Cardiovascular Conditions, but Deemed Too Expensive
Weight loss drugs like tirzepatide and semaglutide are growing in popularity and offer significant health benefits, but they ...
Semaglutide and tirzepatide confer greater improvements in life expectancy than naltrexone/bupropion and ...
In their own responses to the senators’ inquiries last fall, both Pfizer and Lilly emphasized the independence of their ...
The Maryland-based biopharma joins Eli Lilly and Novo Nordisk in trialing a GLP-1 agonist for alcohol- and liver-related ...
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.
On March 5, 2025, the U.S. District Court for the Northern District of Texas denied the Outsourcing Facilities Association’s motion for a ...
We recently published a list of the 11 Best Pharma Stocks to Buy According to Hedge Funds. In this article, we are going to ...
The deal gives the Swiss pharma access to an experimental amylin-targeting treatment it will test in combination with drugs ...
WASHINGTON, D.C. U.S. Senate Democratic Whip Dick Durbin (D-IL) sent letters to five telehealth companies that have held ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results